维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="Hegi M E"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	MGMT gene silencing and benefit from temozolomide in glioblastoma 显示文摘	HEGI M E DISERENS A C GORLIA T	2005	New England Journal of Medicine2005，352，10：	1
2	Correlation of O6methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity 显示文摘	Hegi M E Liu L Herman J G	2008	J Clin Oncol2008，26，25：	1
3	MOMTgene silencing and benefit from temozolomide in gliohlas-toma显示文摘	HEGI M E DISEKENS A CXrORLIA T	2005	N Engl J Med2005，352，：	1
4	MGMT gene silencing and benefit from temozolomide in glioblas- toma显示文摘	HEGI M E DISERENS A C GORLIA T	2005	N Engl J Med2005，352，10：	1
5	MGMT gene silencing aud benefit from temozolomide in glioblastoma显示文摘	DISERENS A C GORLIA T	2005	N En-gl J Med2005，352，10：	1
6	Clinical trial substantiates the predictive value of O^6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide 显示文摘	HEGI M E DISERENS A C GODARD S	2004	Clin Can cer Res2004，10，6：	1
7	MGMT gene silencing and benefit from temozolomide in glioblastoma显示文摘	Hegi M E Diserens A C Gorlia T	2005	N Engl J Med2005，352，10：	1
8	MGMT gene silencing and benefit from temozolomide in glioblastoma 显示文摘	HEGI M E DISERENS A C GORLIA T	2005	N Engl J Med2005，352，10：	1
9	Targeting brain-tumor stem cells显示文摘	STUPP R HEGI ME	2007	Nat Biotechnol2007，25，3：	1
10	MGMT gene silencing and benefit from temozolomide in gliobtastoma显示文摘	Hegi M E Diserens A C Corlia T	2005	N Engl J Med2005，352，10：	1
11	Effect of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trail 显示文摘	Stupp R Hegi M E Mason W P	2009	Lancet Oncol2009，10，5：	1
12	Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study:5-year analysis of the EORTC-NCIC trial显示文摘	STUPP R HEGI M E MASON W P	2009	Lancet Oncol2009，10，5：	1
13	MGMT gene silencing and benefit from temozolomide in glioblastoma显示文摘	Hegi M E Diserens A C Gorlla T	2005	N Engl J Med2005，352，10：	1
14	Clinical trial substantiates the predictive value of O 6-methylguanine-DNA methyltransferase pr-omoter methylation in glioblastoma patients treated with temozolom-ide显示文摘	Hegi M E Diserens A C Godard S	2004	Clin Cancer Res2004，10，6：	1
15	Chemoradiontherapy in malignant glioma: standard of Care and future directions显示文摘	Stupp R Hegi M E Gilbert M R	2007	J Clin Oncol2007，25，26：	1
16	Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase llI study: 5-year analysis of the EORTC-NCIC trial显示文摘	Stupp R Hegi M E Mason W P	2009	Lancet Oncol2009，10，5：	1
17	Recent developments in the use of chemotherapy in brain tumours显示文摘	VAN DEN BENT M J HEGI M E STUPP R	2006	Eur J Cancer2006，42，5：	1
18	MGMT gene silencing and benefit from temozolomide in glioblastoma显示文摘	HEGI M E DISERENS A C GORLIA T	2005	N Engl J Med2005，352，10：	1
19	Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide显示文摘	HEGI M E DISERENS A C GODARD S	2004	Clin Cancer Res2004，10，6：	1
20	MGMT gene silencing and benefit from temozolomide in glioblastoma显示文摘	Hegi M E Diserens A C Gorlia T	2005	N Engl J Med2005，352，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示